With political savvy and outrage over drug prices, advocate David Mitchell was ahead of his time

About a dozen years ago, I was interviewing for a job at The Wall Street Journal when I was asked by an editor what I thought would be the most important story in the coming year for the pharmaceutical industry.

“Pricing,” I responded immediately.